These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30722780)

  • 1. High level of treatment failure and drug resistance to first-line antiretroviral therapies among HIV-infected children receiving decentralized care in Senegal.
    Cissé AM; Laborde-Balen G; Kébé-Fall K; Dramé A; Diop H; Diop K; FatouNiasse-Traoré ; Coulibaly M; Have NN; Vidal N; Thiam S; Wade AS; Peeters M; Taverne B; Msellati P; Touré-Kane C
    BMC Pediatr; 2019 Feb; 19(1):47. PubMed ID: 30722780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral treatment outcome in HIV-1-infected patients routinely followed up in capital cities and remote areas of Senegal, Mali and Guinea-Conakry.
    Diouara AA; Ndiaye HD; Guindo I; Bangoura N; Cissé M; Edmond T; Bougoudogo F; Mboup S; Peeters M; Ayouba A; Kane NC
    J Int AIDS Soc; 2014; 17(1):19315. PubMed ID: 25527333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic: A cross-sectional study.
    Mossoro-Kpinde CD; Gody JC; Mboumba Bouassa RS; Mbitikon O; Jenabian MA; Robin L; Matta M; Zeitouni K; Longo JD; Costiniuk C; Grésenguet G; Touré Kane NC; Bélec L
    Medicine (Baltimore); 2017 Mar; 96(10):e6282. PubMed ID: 28272247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High HIV-1 Virological Failure and Drug Resistance among Adult Patients Receiving First-Line ART for At least 12 Months at a Decentralized Urban HIV Clinic Setting in Senegal before the Test-and-Treat.
    Ekollo Mbange A; Malick Diouara AA; Diop-Ndiaye H; Diaw Diouf NA; Ngom-Ngueye NF; Ndiaye Touré K; Dieng A; Lô S; Fall M; Fon Mbacham W; Mboup S; Touré-Kane C
    Infect Dis (Auckl); 2021; 14():11786337211014503. PubMed ID: 34025122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.
    Dahourou DL; Amorissani-Folquet M; Malateste K; Amani-Bosse C; Coulibaly M; Seguin-Devaux C; Toni T; Ouédraogo R; Blanche S; Yonaba C; Eboua F; Lepage P; Avit D; Ouédraogo S; Van de Perre P; N'Gbeche S; Kalmogho A; Salamon R; Meda N; Timité-Konan M; Leroy V;
    BMC Med; 2017 Apr; 15(1):85. PubMed ID: 28434406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.
    Charpentier C; Gody JC; Mbitikon O; Moussa S; Matta M; Péré H; Fournier J; Longo Jde D; Bélec L
    AIDS Res Hum Retroviruses; 2012 Jan; 28(1):87-94. PubMed ID: 21599597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
    Aghokeng AF; Monleau M; Eymard-Duvernay S; Dagnra A; Kania D; Ngo-Giang-Huong N; Toni TD; Touré-Kane C; Truong LX; Delaporte E; Chaix ML; Peeters M; Ayouba A;
    Clin Infect Dis; 2014 Jan; 58(1):99-109. PubMed ID: 24076968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of virological failure among HIV infected children and adolescents receiving second-line antiretroviral therapy in Uganda, a retrospective study.
    Musiime-Mwase F; Nakanjako D; Kanywa JB; Nasuuna EM; Naitala R; Oceng R; Sewankambo N; Elyanu P
    BMC Infect Dis; 2024 Sep; 24(1):1057. PubMed ID: 39333946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virological response and resistances over 12 months among HIV-infected children less than two years receiving first-line lopinavir/ritonavir-based antiretroviral therapy in Cote d'Ivoire and Burkina Faso: the MONOD ANRS 12206 cohort.
    Amani-Bosse C; Dahourou DL; Malateste K; Amorissani-Folquet M; Coulibaly M; Dattez S; Emieme A; Barry M; Rouzioux C; N'gbeche S; Yonaba C; Timité-Konan M; Mea V; Ouédraogo S; Blanche S; Meda N; Seguin-Devaux C; Leroy V
    J Int AIDS Soc; 2017 Apr; 20(1):21362. PubMed ID: 28453240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
    Sylla M; Dolo O; Maiga AI; Traore FT; Coulibaly YA; Togo J; Fofana DB; Dicko-Traore F; Doumbia S; Orsega S; Diallo S; Murphy RL; Calvez V; Marcelin AG
    Arch Pediatr; 2019 Jul; 26(5):254-258. PubMed ID: 31307909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of virological failure and antiretroviral drug resistance in Mozambique.
    Rupérez M; Pou C; Maculuve S; Cedeño S; Luis L; Rodríguez J; Letang E; Moltó J; Macete E; Clotet B; Alonso P; Menéndez C; Naniche D; Paredes R
    J Antimicrob Chemother; 2015 Sep; 70(9):2639-47. PubMed ID: 26084302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali.
    Germanaud D; Derache A; Traore M; Madec Y; Toure S; Dicko F; Coulibaly H; Traore M; Sylla M; Calvez V; Marcelin AG
    J Antimicrob Chemother; 2010 Jan; 65(1):118-24. PubMed ID: 19933171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
    Judd A; Lodwick R; Noguera-Julian A; Gibb DM; Butler K; Costagliola D; Sabin C; van Sighem A; Ledergerber B; Torti C; Mocroft A; Podzamczer D; Dorrucci M; De Wit S; Obel N; Dabis F; Cozzi-Lepri A; García F; Brockmeyer NH; Warszawski J; Gonzalez-Tome MI; Mussini C; Touloumi G; Zangerle R; Ghosn J; Castagna A; Fätkenheuer G; Stephan C; Meyer L; Campbell MA; Chene G; Phillips A;
    HIV Med; 2017 Mar; 18(3):171-180. PubMed ID: 27625109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
    Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
    Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of dried blood spots for HIV viral load monitoring in decentralized area in North Vietnam in a test-and-treat era, the MOVIDA project.
    Nguyen TA; Tran TH; Nguyen BT; Pham TTP; Hong Le NT; Ta DV; Phan HTT; Nguyen LH; Ait-Ahmed M; Ho HT; Taieb F; Madec Y;
    PLoS One; 2020; 15(4):e0230968. PubMed ID: 32271796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
    Loubet P; Charpentier C; Visseaux B; Borbor A; Nuta C; Adu E; Chapplain JM; Baysah M; Tattevin P; Yazdanpanah Y; Descamps D
    J Antimicrob Chemother; 2015; 70(6):1881-4. PubMed ID: 25698771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dried blood spots for HIV-1 drug resistance genotyping in decentralized settings in Senegal.
    Diouara AA; Diop-Ndiaye H; Kebe-Fall K; Tchiakpè E; Ndiaye O; Ayouba A; Peeters M; Mboup S; Kane CT
    J Med Virol; 2014 Jan; 86(1):45-51. PubMed ID: 24122937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.
    Zoufaly A; Fillekes Q; Hammerl R; Nassimi N; Jochum J; Drexler JF; Awasom CN; Sunjoh F; Burchard GD; Burger DM; van Lunzen J; Feldt T
    Antivir Ther; 2013; 18(5):681-90. PubMed ID: 23502762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda.
    Nasuuna E; Kigozi J; Babirye L; Muganzi A; Sewankambo NK; Nakanjako D
    BMC Public Health; 2018 Aug; 18(1):1048. PubMed ID: 30134880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.